FDA Announces Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to drug and biological product user fee waivers, reductions, and refunds, which has been submitted to the Office of Management and Budget (OMB) for review and clearance